Consensus Transgene

Equities

TNG

FR0005175080

Market Closed - Euronext Paris Other stock markets 11:35:05 2024-04-19 am EDT			5-day change	1st Jan Change
1.382 ^EUR	-5.08%		-1.29%	+0.88%

Apr. 10	Transgene: presents vaccine results at AACR	CF
Mar. 28	Transgene CFO Steps Down; Successor Assumes Office	MT

Evolution of the average Target Price on Transgene

Price target over the last 5 years

History of analyst recommendation changes

fdf8b73caa9ea0ae.j6iIZa5TdqpaM2qMlYBwm7JEjKDitDk065H8dv_uWso.7uLgEJw8N55oUj_Y3ugH1PZ13Niw019cmaHIMKqLGL7KnbgK-zIv-jlRUg~ee727608ab0248eeca689befce5b943b

Analyst Recommendations on Transgene

Exane BNP Paribas Health Care Conference

17-03-12

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.382 EUR

Average target price

3.5 EUR

Spread / Average Target

+153.26%

High Price Target

3.5 EUR

Spread / Highest target

+153.26%

Low Price Target

3.5 EUR

Spread / Lowest Target

+153.26%

Consensus detail

Consensus revision (last 18 months)

Ratings for Transgene

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar